The drugs being recalled are used to treat patients with high blood pressure to prevent heart attacks and stroke.
An impurity, N-nitrosodimethylamine, was found in the valsartan used in these medications, supplied by a Chinese company, Zhejiang Huahai Pharmaceuticals.
According to the United States Environmental Protection Agency, this substance is a potential carcinogen that could cause cancer and liver damage over the long-term.
Here’s a list of the affected medications, provided by Health Canada. For a complete list including drug identification and lot numbers, visit their website:
- ACT-VALSARTAN 40MG FC TABLETS 100
- ACT-VALSARTAN 80MG FC TABLETS 100
- ACT-VALSARTAN 160MG FC TABLETS 100
- SANDOZ VALSARTAN 40 MG
- SANDOZ VALSARTAN 80 MG
- SANDOZ VALSARTAN 160 MG
- SANDOZ VALSARTAN 320 MG
- SANIS VALSARTAN 40 MG
- SANIS VALSARTAN 80 MG
- SANIS VALSARTAN 160 MG
- PRO DOC LIMITEE VALSARTAN 40 MG
- PRO DOC LIMITEE VALSARTAN 80 MG
- PRO DOC LIMITEE VALSARTAN 160 MG
- PRO DOC LIMITEE VALSARTAN 320 MG
- SIVEM PHARMACEUTICAL ULC VALSARTAN 40 MG
- SIVEM PHARMACEUTICAL ULC VALSARTAN 80 MG
- SIVEM PHARMACEUTICAL ULC VALSARTAN 160 MG
- SIVEM PHARMACEUTICAL ULC VALSARTAN 320 MG
- TEVA-VALSARTAN/HCTZ TABLETS PP 30s
- TEVA-VALSARTAN/HCTZ TABLETS (Bulk)